Release date: 7/1/2021
Expiration date: 7/1/2022
This independent self-study activity is designed for physicians, physician assistants, pharmacists, nursing professionals at all levels and other healthcare professionals.
Upon completion of the educational activity, the learner should be able to:
- Define pediatric abusive head trauma.
- Recognize current incidence, prevalence, and trends of “pediatric abusive head trauma” or “pediatric AHT”.
- Characterize risk factors often associated with pediatric AHT.
- Review basic head and neck pathophysiology in children less than 5 years of age and how these characteristics exacerbate injuries related to shaking and head trauma.
- Identify strategies that have been successfully used to elicit historical information from the parent, caregiver, or child.
- Outline physical assessment findings and diagnostic findings leading to presumed diagnosis of pediatric AHT.
- Summarize Kentucky reporting requirements when any form of child abuse or neglect including pediatric AHT is suspected.
- Describe suggested resources to educate, prevent, and promote awareness of pediatric AHT.
Method of Participation
In order to receive credit, participants should read the entire monograph, complete and submit an evaluation and score at least 70% on the self-assessment test. Certificates will be available in the transcripts upon successful completion of the self-assessment test. If you have questions about this CE activity, please contact AKH Inc. at [email protected].
CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit being awarded: 1.5 ANCC contact hours
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until 7/1/2024. PAs should only claim credit commensurate with the extent of their participation.
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.5 contact hours.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030083. This activity is approved for 1.5 contact hour(s) which includes 0 hour(s) of pharmacology.
As a Jointly Accredited Organization, AKH Inc., Advancing Knowledge in Healthcare is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AKH Inc. Advancing Knowledge in Healthcare maintains responsibility for this course. Social workers completing this course receive 1.5 continuing education credits.
Mary Kathleen Ebener PhD, RN (author)
Dorothy Caputo, MA, BSN, RN (CE Director of Accreditations), Dorothy Duffy, BS Pharmacy (Pharmacy Reviewer), Bernadette M. Makar, MSN, APRN, BC, NP-C (Nurse Practitioner) and AKH staff.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All of the relevant financial relationships listed for these individuals have been mitigated.
There is no commercial support for this activity.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCT
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.